tert-Butyl (1-hydroxy-4-methylpentan-2-yl)carbamate

Catalog No. :
ACISNT479
CAS No. :
142121-48-0
Molecular Formula :
C11H23NO3
Molecular Weight :
217.31

IUPAC Name:tert-butyl (1-hydroxy-4-methylpentan-2-yl)carbamate

tert-Butyl (1-hydroxy-4-methylpentan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$59.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1-hydroxy-4-methylpentan-2-yl)carbamate
IUPAC Nametert-butyl (1-hydroxy-4-methylpentan-2-yl)carbamate
MDL No.MFCD01883028
Molecular FormulaC11H23NO3
Molecular Weight217.31
SMILESO=C(OC(C)(C)C)NC(CC(C)C)CO
InChI KeyLQTMEOSBXTVYRM-UHFFFAOYSA-N
SynonymBB 0263072 | CS-0154066 | EX-A055 | 2-fluoro-N-((3R,4R)-3-methylpiperidin-4-yl)-N-propylbenzamide | Boc-DL-Leucinol | MFCD01883028 | SCHEMBL1059380 | FT-0686545 | Carbamic acid,N-[1-(hydroxymethyl)-3-methylbutyl]-,1,1-dimethylethyl ester | SY042575 | A807
CAS No.142121-48-0
PubChem CID546110

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACISNT479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYBFC049 route compound structure diagram
    ACYBFC049502-32-9 In Stock
  4. Then
  5. ACISNT479 route product structure diagram
    ACISNT479142121-48-0 In Stock
Inquiry

2. ACISNT479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACYBFC049 route compound structure diagram
    ACYBFC049502-32-9 In Stock
  6. Then
  7. ACISNT479 route product structure diagram
    ACISNT479142121-48-0 In Stock
Inquiry

Comments (0)